A detailed history of Cullen Investment Group, Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 12,890 shares of LLY stock, worth $11.6 Million. This represents 1.86% of its overall portfolio holdings.

Number of Shares
12,890
Previous 13,573 5.03%
Holding current value
$11.6 Million
Previous $10.4 Billion 12.55%
% of portfolio
1.86%
Previous 1.63%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 01, 2024

SELL
$724.87 - $909.04 $495,086 - $620,874
-683 Reduced 5.03%
12,890 $11.7 Billion
Q1 2024

Apr 04, 2024

SELL
$592.2 - $792.28 $50,929 - $68,136
-86 Reduced 0.63%
13,573 $10.4 Billion
Q4 2023

Jan 30, 2024

BUY
$525.19 - $619.13 $7.17 Million - $8.46 Million
13,659 New
13,659 $7.96 Billion

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $858B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.